Literature DB >> 30958514

Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.

Jojo Y Y Kwok1, Jackie C Y Kwan2, M Auyeung3, Vincent C T Mok4, Claire K Y Lau5, K C Choi6, Helen Y L Chan6.   

Abstract

Importance: Clinical practice guidelines support exercise for patients with Parkinson disease (PD), but to our knowledge, no randomized clinical trials have tested whether yoga is superior to conventional physical exercises for stress and symptom management. Objective: To compare the effects of a mindfulness yoga program vs stretching and resistance training exercise (SRTE) on psychological distress, physical health, spiritual well-being, and health-related quality of life (HRQOL) in patients with mild-to-moderate PD. Design, Setting, and Participants: An assessor-masked, randomized clinical trial using the intention-to-treat principle was conducted at 4 community rehabilitation centers in Hong Kong between December 1, 2016, and May 31, 2017. A total of 187 adults (aged ≥18 years) with a clinical diagnosis of idiopathic PD who were able to stand unaided and walk with or without an assistive device were enrolled via convenience sampling. Eligible participants were randomized 1:1 to mindfulness yoga or SRTE. Interventions: Mindfulness yoga was delivered in 90-minute groups and SRTE were delivered in 60-minute groups for 8 weeks. Main Outcomes and Measures: Primary outcomes included anxiety and depressive symptoms assessed using the Hospital Anxiety and Depression Scale. Secondary outcomes included severity of motor symptoms (Movement Disorder Society Unified Parkinson's Disease Rating Scale [MDS-UPDRS], Part III motor score), mobility, spiritual well-being in terms of perceived hardship and equanimity, and HRQOL. Assessments were done at baseline, 8 weeks (T1), and 20 weeks (T2).
Results: The 138 participants included 65 men (47.1%) with a mean (SD) age of 63.7 (8.7) years and a mean (SD) MDS-UPDRS score of 33.3 (15.3). Generalized estimating equation analyses revealed that the yoga group had significantly better improvement in outcomes than the SRTE group, particularly for anxiety (time-by-group interaction, T1: β, -1.79 [95% CI, -2.85 to -0.69; P = .001]; T2: β, -2.05 [95% CI, -3.02 to -1.08; P < .001]), depression (T1: β, -2.75 [95% CI, -3.17 to -1.35; P < .001]); T2: β, -2.75 [95% CI, -3.71 to -1.79; P < .001]), perceived hardship (T1: β, -0.92 [95% CI, -1.25 to -0.61; P < .001]; T2: β, -0.76 [95% CI, -1.12 to -0.40; P < .001]), perceived equanimity (T1: β, 1.11 [95% CI, 0.79-1.42; P < .001]; T2: β, 1.19 [95% CI, 0.82-1.56; P < .001]), and disease-specific HRQOL (T1: β, -7.77 [95% CI, -11.61 to -4.38; P < .001]; T2: β, -7.99 [95% CI, -11.61 to -4.38; P < .001]). Conclusions and Relevance: Among patients with mild-to-moderate PD, the mindfulness yoga program was found to be as effective as SRTE in improving motor dysfunction and mobility, with the additional benefits of a reduction in anxiety and depressive symptoms and an increase in spiritual well-being and HRQOL. Trial Registration: Centre for Clinical Research and Biostatistics identifier: CUHK_CCRB00522.

Entities:  

Year:  2019        PMID: 30958514      PMCID: PMC6583059          DOI: 10.1001/jamaneurol.2019.0534

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  41 in total

1.  High intensity eccentric resistance training decreases bradykinesia and improves Quality Of Life in persons with Parkinson's disease: a preliminary study.

Authors:  Leland E Dibble; Tessa F Hale; Robin L Marcus; J Parry Gerber; Paul C LaStayo
Journal:  Parkinsonism Relat Disord       Date:  2009-06-03       Impact factor: 4.891

2.  The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review.

Authors:  Stefan G Hofmann; Alice T Sawyer; Ashley A Witt; Diana Oh
Journal:  J Consult Clin Psychol       Date:  2010-04

Review 3.  Pharmacological treatment of Parkinson disease: a review.

Authors:  Barbara S Connolly; Anthony E Lang
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

4.  Minimal detectable change of the timed "up & go" test and the dynamic gait index in people with Parkinson disease.

Authors:  Sheau-Ling Huang; Ching-Lin Hsieh; Ruey-Meei Wu; Chun-Hwei Tai; Chin-Hsien Lin; Wen-Shian Lu
Journal:  Phys Ther       Date:  2010-10-14

5.  Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease.

Authors:  Carmen Rodriguez-Blazquez; Belen Frades-Payo; Maria João Forjaz; Jesus de Pedro-Cuesta; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

6.  A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.

Authors:  Daniel M Corcos; Julie A Robichaud; Fabian J David; Sue E Leurgans; David E Vaillancourt; Cynthia Poon; Miriam R Rafferty; Wendy M Kohrt; Cynthia L Comella
Journal:  Mov Disord       Date:  2013-03-27       Impact factor: 10.338

7.  Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism.

Authors:  Teresa Steffen; Megan Seney
Journal:  Phys Ther       Date:  2008-03-20

8.  Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective.

Authors:  C M Leung; S Ho; C S Kan; C H Hung; C N Chen
Journal:  Int J Psychosom       Date:  1993

9.  The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice.

Authors:  Ingrid Olssøn; Arnstein Mykletun; Alv A Dahl
Journal:  BMC Psychiatry       Date:  2005-12-14       Impact factor: 3.630

Review 10.  Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs.

Authors:  Rinske A Gotink; Paula Chu; Jan J V Busschbach; Herbert Benson; Gregory L Fricchione; M G Myriam Hunink
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

View more
  42 in total

1.  The role of dispositional mindfulness in a stress-health pathway among Parkinson's disease patients and caregiving partners.

Authors:  Allison Hicks; Kala Phillips; Chelsea Siwik; Paul Salmon; Irene Litvan; Megan E Jablonski; J Vincent Filoteo; Karen Kayser; Sandra E Sephton
Journal:  Qual Life Res       Date:  2019-06-14       Impact factor: 4.147

Review 2.  Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Authors:  Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2019-12-05       Impact factor: 3.575

Review 3.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

Review 4.  Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis.

Authors:  Lisa M Deuel; Lauren C Seeberger
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 5.  Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease.

Authors:  Tyler A Steele; Erik K St Louis; Aleksandar Videnovic; R Robert Auger
Journal:  Neurotherapeutics       Date:  2021-04-12       Impact factor: 7.620

Review 6.  Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease.

Authors:  Terry D Ellis; Cristina Colón-Semenza; Tamara R DeAngelis; Cathi A Thomas; Marie-Hélène Saint Hilaire; Gammon M Earhart; Leland E Dibble
Journal:  Semin Neurol       Date:  2021-03-19       Impact factor: 3.420

Review 7.  The neuropsychiatry of Parkinson's disease: advances and challenges.

Authors:  Daniel Weintraub; Dag Aarsland; Kallol Ray Chaudhuri; Roseanne D Dobkin; Albert Fg Leentjens; Mayela Rodriguez-Violante; Anette Schrag
Journal:  Lancet Neurol       Date:  2022-01       Impact factor: 44.182

Review 8.  Four-Repeat Tauopathies: Current Management and Future Treatments.

Authors:  Lawren VandeVrede; Peter A Ljubenkov; Julio C Rojas; Ariane E Welch; Adam L Boxer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

9.  A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson's disease.

Authors:  Agnes Langer; Sebastian Hasenauer; Anna Flotz; Lucia Gassner; Rochus Pokan; Peter Dabnichki; Laurenz Wizany; Jakob Gruber; Dominik Roth; Sarah Zimmel; Marco Treven; Michaela Schmoeger; Ulrike Willinger; Walter Maetzler; Heidemarie Zach
Journal:  NPJ Parkinsons Dis       Date:  2021-06-10

10.  Role of Adiponectin-Notch pathway in cognitive dysfunction associated with depression and in the therapeutic effect of physical exercise.

Authors:  Jingjing You; Linshan Sun; Jiangong Wang; Fengjiao Sun; Wentao Wang; Dan Wang; Xueli Fan; Dunjiang Liu; Zhicheng Xu; Changyun Qiu; Jinbo Chen; Haijing Yan; Bin Liu
Journal:  Aging Cell       Date:  2021-05-30       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.